APA (7th ed.) Citation

S, P., K, M., A, M., & A, P. (2026). From Failure to Promise: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition in Atherosclerotic Cardiovascular Disease. Journal of the American Heart Association, 15(9), e047676. https://doi.org/10.1161/JAHA.125.047676

Chicago Style (17th ed.) Citation

S, Prajapathi, Mahajan K, Mohta A, and Pradhan A. "From Failure to Promise: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition in Atherosclerotic Cardiovascular Disease." Journal of the American Heart Association 15, no. 9 (2026): e047676. https://doi.org/10.1161/JAHA.125.047676.

MLA (9th ed.) Citation

S, Prajapathi, et al. "From Failure to Promise: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition in Atherosclerotic Cardiovascular Disease." Journal of the American Heart Association, vol. 15, no. 9, 2026, p. e047676, https://doi.org/10.1161/JAHA.125.047676.